| 61 |
|
Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose/
|
Bachar-Lustig, E
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 62 |
|
Antitumor effect of donor marrow graft rejection induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: critical role for recipient-derived IFN-gamma/
|
Rubio, M.-T
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 63 |
|
An update on how to treat chronic GVHD/
|
Flowers, M. E. D
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 64 |
|
Ara-G Fas L-itates T-cell death/
|
Smith, B. D
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 65 |
|
Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells/
|
Nasr, R
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 66 |
|
Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G~1 or G~2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL/
|
Liu, Q
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 67 |
|
Asp1424Asn MYH9 mutation results in an unstable protein responsible for the phenotypes in May-Hegglin anomaly/Fechtner syndrome/
|
Deutsch, S
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 68 |
|
Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants/
|
Freudenberger, T. D
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 69 |
|
ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y~1~1 receptor signaling/
|
Schnurr, M
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 70 |
|
Attenuated signaling by a phosphotyrosine-null Epo receptor form in primary erythroid progenitor cells/
|
Li, K
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 71 |
|
Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System/
|
Jaroscak, J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 72 |
|
Author guide ///
|
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 73 |
|
Author guide ///
|
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 74 |
|
Author guide ///
|
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 75 |
|
Author guide ///
|
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 76 |
|
Autologous transplantation of granulocyte colony-stimulating factor-primed bone marrow is effective in supporting myeloablative chemotherapy in patients with hematologic malignancies and poor peripheral blood stem cell mobilization/
|
Lemoli, R. M
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 77 |
|
The ABO gene-more variation!/
|
Blumenfeld, O. O
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 78 |
|
The amino terminal and E2F interaction domains are critical for C/EBPalpha-mediated induction of granulopoietic development of hematopoietic cells/
|
D Alo , F
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 79 |
|
The APC-independent anticoagulant activity of protein S in plasma is decreased by elevated prothrombin levels due to the prothrombin G20210A mutation/
|
Koenen, R. R
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|